| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.45B | 39.89B | 35.63B | 33.40B | 27.49B | 24.32B |
| Gross Profit | 15.98B | 14.97B | 13.26B | 12.02B | 7.83B | 9.62B |
| EBITDA | 8.73B | 8.09B | 7.33B | 6.67B | 6.34B | 5.34B |
| Net Income | -1.50B | -784.96M | 168.94M | 674.52M | 1.28B | 1.53B |
Balance Sheet | ||||||
| Total Assets | 83.14B | 83.18B | 70.98B | 57.40B | 47.07B | 36.66B |
| Cash, Cash Equivalents and Short-Term Investments | 2.57B | 6.30B | 5.39B | 3.65B | 3.78B | 5.10B |
| Total Debt | 38.46B | 39.51B | 33.54B | 22.93B | 17.46B | 11.74B |
| Total Liabilities | 63.62B | 63.05B | 52.91B | 40.26B | 32.59B | 23.50B |
| Stockholders Equity | 19.52B | 20.13B | 18.07B | 17.15B | 14.48B | 13.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.67B | -7.39B | -4.87B | -5.13B | 3.21B |
| Operating Cash Flow | 0.00 | 8.65B | 4.98B | 8.34B | 2.24B | 6.97B |
| Investing Cash Flow | 0.00 | -12.32B | -12.26B | -13.59B | -7.59B | -3.62B |
| Financing Cash Flow | 0.00 | 4.73B | 7.44B | 4.94B | 4.17B | 618.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $1.22B | 14.58 | 26.17% | 0.47% | 2.52% | 10.02% | |
62 Neutral | $992.33M | -60.25 | -7.83% | ― | 5.81% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
52 Neutral | $835.05M | -16.17 | -4.06% | 0.97% | 11.59% | -106.83% | |
52 Neutral | $554.89M | 48.21 | 13.13% | ― | 102.05% | -110.74% | |
49 Neutral | $1.70B | -2.42 | -86.86% | ― | -0.83% | -25.72% | |
47 Neutral | $548.84M | -1.79 | -23.85% | 10.11% | -4.94% | -335.70% |